I Herrero
Overview
Explore the profile of I Herrero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
498
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Anchordoqui M, De Belder D, Lucero C, Rapoport M, Faccone D, Rodriguez A, et al.
J Glob Antimicrob Resist
. 2016 Nov;
3(3):210-213.
PMID: 27873711
This study investigated the molecular characteristics of six bla-positive Enterobacteriaceae recovered from three patients in Argentina. Antimicrobial susceptibility testing was performed following Clinical and Laboratory Standards Institute (CLSI) 2014 recommendations....
2.
Torre-Cisneros J, Aguado J, Caston J, Almenar L, Alonso A, Cantisan S, et al.
Transplant Rev (Orlando)
. 2016 May;
30(3):119-43.
PMID: 27132815
Cytomegalovirus (CMV) infection remains a major complication of solid organ transplantation. Because of management of CMV is variable among transplant centers, in 2011 the Spanish Transplantation Infection Study Group (GESITRA)...
3.
Rotellar F, Pardo F, Benito A, Marti-Cruchaga P, Zozaya G, Lopez L, et al.
Am J Transplant
. 2013 Nov;
13(12):3269-73.
PMID: 24266975
The overriding concern in living donor liver transplantation is donor safety. A totally laparoscopic right hepatectomy without middle hepatic vein for adult living donor liver transplantation is presented. The surgical...
4.
A phase I clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma
Sangro B, Mazzolini G, Ruiz M, Ruiz J, Quiroga J, Herrero I, et al.
Cancer Gene Ther
. 2010 Aug;
17(12):837-43.
PMID: 20689572
The aim of this phase I clinical trial was to assess the feasibility and safety of intratumoral administration of a first-generation adenoviral vector encoding herpes simplex virus thymidine kinase (HSV-TK)...
5.
Scholbach T, Herrero I, Scholbach J
J Pediatr Gastroenterol Nutr
. 2004 Dec;
39(5):524-8.
PMID: 15572893
Objective: Chronic inflammatory bowel diseases are characterized by inflammatory hyperperfusion of the intestinal wall in affected bowel segments. We applied a novel method to quantify color Doppler signals dynamically along...
6.
Regueira F, Diez-Caballero A, Herrero I, Rotellar F, Hernandez Lizoain J, Quiroga J, et al.
Transplant Proc
. 2002 Apr;
34(1):231-2.
PMID: 11959259
No abstract available.
7.
Castellvi J, Borobia F, Figueras J, Fradera R, Herrero I, Torras J, et al.
Transplant Proc
. 2002 Apr;
34(1):50-2.
PMID: 11959181
No abstract available.
8.
Lloberas N, Torras J, Herrero I, Cruzado J, Riera M, Grinyo J
Transplant Proc
. 2002 Apr;
34(1):47-8.
PMID: 11959179
No abstract available.
9.
Riera M, Torras J, Cruzado J, Lloberas N, Liron J, Herrero I, et al.
Transplantation
. 2001 Oct;
72(7):1217-23.
PMID: 11602845
Background: Cyclic nucleotide analogue administration improves ischemia-reperfusion damage in several organs. The neuropeptide pituitary adenylate cyclase-activating polypeptide, PACAP-38, is a potent stimulus to enhance cellular cAMP levels. This study tested...
10.
Thomson M, Delgado E, Manjon N, Ocampo A, Villahermosa M, Marino A, et al.
AIDS
. 2001 Mar;
15(4):509-16.
PMID: 11242148
Background: The HIV-1 epidemics in Western Europe are dominated by B subtype viruses. Non-B subtype is largely restricted to individuals infected outside of Europe and to their direct contacts and...